MRNA vs NCLH · rev $145.0M vs P/E 16, rev $4.97B
Moderna Inc (MRNA) versus Norwegian Cruise Line Holdings Ltd (NCLH) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Norwegian Cruise Line Holdings Ltd (NCLH) is a travel services company listed on NYSE.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported NCLH revenue for 2026-06-30 was $4.97B. Net income was $327.2M. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
MRNA currently screens at market cap $24.52B. NCLH currently screens at market cap $9.10B and trailing P/E 16.0.
Not investment advice. Open the MRNA and NCLH stock pages for the full models.
Not investment advice.